Cockroach-induced IL9, IL13, and IL31 expression and the development of allergic asthma in urban children - 05/05/21
Doi : 10.1016/j.jaci.2021.01.022
Petra LeBeau, ScD a, ∗, Alexandre Lockhart, MS a, ∗, Alkis Togias, MD b, Megan T. Sandel, MD c, Jessica D. Gereige, MD c, Leonard Bacharier, MD d, Stephanie Lovinsky-Desir, MD e, Robert A. Wood, MD f, Robert James, PhD a, William W. Busse, MD g, James E. Gern, MD g, Matthew C. Altman, MD h, i 
for the
for the
National Institute of Allergy and Infectious Diseases-Sponsored Inner-City Asthma Consortium
a Rho Inc, Durham, NC
b US National Institute of Allergy and Infectious Diseases, Bethesda, Md
c Boston University School of Medicine, Boston, Mass
d Washington University School of Medicine, St Louis, Mo
e Columbia University College of Physicians and Surgeons, New York, NY
f Johns Hopkins University School of Medicine, Baltimore, Md
g University of Wisconsin School of Medicine and Public Health, Madison, Wis
h University of Washington Department of Medicine, Seattle, Wash
i Benaroya Research Institute Systems Immunology Division, Seattle, Wash
| Dr Togias’ coauthorship on this publication does not constitute endorsement by the US National Institute of Allergy and Infectious Diseases or by any other United States government agency. |
|
| Supported with federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health (under contract numbers NO1-AI-25496, NO1-AI-25482, HHSN272200900052C, HHSN272201000052I, 1UM1AI114271-01, and UM2AI117870), as well as with additional support was provided by the National Center for Research Resources, National Institutes of Health (under grants RR00052, M01RR00533, 1UL1RR025771, M01RR00071, 1UL1RR024156, UL1TR000040, UL1TR001079, and 5UL1RR024992-02). All of the authors, with the exception of A.T., J.D.G., and M.C.A., report grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases/Division of Allergy, Immunology, and Transplantation during the conduct of the study. |
|
| Disclosure of potential conflict of interest: L. Bacharier reports personal fees from GlaxoSmithKline, Genentech/Novartis, DBV Technologies, AstraZeneca, WebMD/Medscape, Sanofi/Regeneron, Vectura, and Circassia, as well as personal fees and nonfinancial support from Merck, Teva, and Boehringer Ingelheim outside the submitted work. J. E. Gern reports consulting fees from Regeneron, consulting fees and stock options from Meissa Vaccines, Inc, and consulting fees from AstraZeneca; personal fees from PREP Biopharm, Inc, MedImmune, and Ena Pharmaceuticals; and a pending patent for methods of propagating rhinovirus C in previously unsusceptible cell lines and adapted rhinovirus C outside the submitted work. J. D. Gereige reports grants from the National Institutes of Health (T32) outside the submitted work. W. W. Busse reports personal fees from Boston Scientific, Novartis, GlaxoSmithKline, Genentech, Sanofi/Genzyme, AstraZeneca, Teva, Regeneron, and Elsevier outside the submitted work. R. A. Wood reports grants from DNV, Aimmune, Astellas, HAL-Allergy, and Regeneron and royalties outside the submitted work. M. C. Altman reports personal fees from Sanofi-Regeneron outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2021
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 147 - N° 5
P. 1974 - mai 2021 Retour au numéro
Article précédent
- Downregulation of MCM2 contributes to the reduced growth potential of epithelial progenitor cells in chronic nasal inflammation
- Li Yue Li, Yu Tao Zhou, Lin Sun, Xin Yi Liu, Jian Li, Yue Hong, Xiao Yan Ye, Qing Bao, Qing Xiang Meng, Wei Ping Wen, He Xin Chen, Chun Wei Li
- Agammaglobulinemia with normal B-cell numbers in a patient lacking Bob1
- Patrick Kury, Julian Staniek, Oliver Wegehaupt, Iga Janowska, Matthias Eckenweiler, Rudolf Korinthenberg, Natia Japaridze, Manuela Pendziwiat, Ingo Helbig, Els Verhoeyen, Johannes Jung, Andres Caballero Garcia de Oteyza, Michele Proietti, Tamar Phirtskhalaishvili, Irakli Rtskhiladze, Peter J. Nielsen, Stephan Ehl, Carsten Speckmann, Marta Rizzi
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?